Method for screening drug and chemical effects in laboratory rats using computerized quantitative...

Area of Science:

• Neuroscience
• Pharmacology
• Toxicology

Background:

• Quantitative electroencephalography (qEEG) is crucial for assessing drug effects.
• Existing methods often require anesthesia, limiting their applicability for regulatory testing.
• A minimally-invasive, anesthetic-free qEEG approach is needed for naturalistic stimulation studies.

Purpose of the Study:

• To develop and validate a minimally-invasive, anesthetic-free qEEG method for regulatory drug and chemical testing in rats.
• To assess qEEG parameter changes associated with cholinesterase inhibition using physostigmine.
• To evaluate qEEG responses to an M2 autoreceptor agonist, oxotremorine.

Main Methods:

• Developed and validated an anesthetic-free qEEG technique in Fischer 344 and Sprague-Dawley rats.
• Administered physostigmine (0.05-1.0 mg/kg) to measure dose-dependent cholinesterase inhibition and qEEG changes.
• Administered oxotremorine (0.05-0.2 mg/kg) to assess M2 autoreceptor agonist effects on qEEG parameters.

Main Results:

• Physostigmine administration correlated dose-dependently with cholinesterase inhibition and increased total power/amplitude.
• Treatment-related qEEG effects included decreased alpha/beta, increased delta, and a left-shift in spectral-edge frequency.
• Oxotremorine increased beta, shifted spectral-edge frequency rightward, and decreased alpha, consistent with muscarinic effects.

Conclusions:

• The developed anesthetic-free qEEG method is reliable for regulatory testing of drugs and chemicals.
• qEEG parameters effectively reflect cholinesterase inhibition and muscarinic receptor activation.
• This method provides a valuable tool for analyzing cholinergic compound effects in preclinical studies.